InfuSystem is the leading provider of ambulatory infusion pumps and associated clinical services for oncologists and their patients in the U.S.

These pumps allow for the gradual delivery of a drug over a period of days in the privacy of one's home, compared to bolus infusion chemotherapy treatments that are given in a single high dose over a short period of time. Improved efficacy of the drugs, patient comfort, reimbursement to doctors for appropriate services and continuity of care all play a role in the growing trend toward this form of treatment. InfuSystem's pumps are primarily used for colorectal cancer, but they have been approved for other forms of cancer, thereby greatly enhancing the market opportunity for InfuSystem. As the leading nationwide provider, InfuSystem is ideally positioned for growth in an expanding and highly fragmented market.